These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 14749472)
1. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes. Nunes M; Shi C; Greenberger LM Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472 [TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor-, epidermal growth factor-, or A-Raf-induced growth of HaCaT keratinocytes requires extracellular signal-regulated kinase. Rössler OG; Thiel G Am J Physiol Cell Physiol; 2004 May; 286(5):C1118-29. PubMed ID: 15075211 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990 [TBL] [Abstract][Full Text] [Related]
4. [EGF-induced signal transduction in clonal cells of epidermoid carcinoma A431]. Grudinkin PS; Bagaeva VV; Nikol'skiĭ NN Tsitologiia; 2003; 45(2):158-65. PubMed ID: 12722480 [TBL] [Abstract][Full Text] [Related]
5. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Tyagi A; Agarwal R; Agarwal C Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755 [TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. Sah JF; Balasubramanian S; Eckert RL; Rorke EA J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854 [TBL] [Abstract][Full Text] [Related]
7. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187 [TBL] [Abstract][Full Text] [Related]
8. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914 [TBL] [Abstract][Full Text] [Related]
9. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Li B; Chang CM; Yuan M; McKenna WG; Shu HK Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544 [TBL] [Abstract][Full Text] [Related]
11. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812 [TBL] [Abstract][Full Text] [Related]
12. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Albanell J; Codony-Servat J; Rojo F; Del Campo JM; Sauleda S; Anido J; Raspall G; Giralt J; Roselló J; Nicholson RI; Mendelsohn J; Baselga J Cancer Res; 2001 Sep; 61(17):6500-10. PubMed ID: 11522647 [TBL] [Abstract][Full Text] [Related]
13. Downstream effectors of oncogenic ras in multiple myeloma cells. Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. Piiper A; Dikic I; Lutz MP; Leser J; Kronenberger B; Elez R; Cramer H; Müller-Esterl W; Zeuzem S J Biol Chem; 2002 Nov; 277(46):43623-30. PubMed ID: 12218049 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. Kaufmann K; Thiel G J Cell Biochem; 2002; 85(2):381-91. PubMed ID: 11948693 [TBL] [Abstract][Full Text] [Related]
17. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Jackson JG; St Clair P; Sliwkowski MX; Brattain MG Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917 [TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226 [TBL] [Abstract][Full Text] [Related]
19. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors. Wright JD; Reuter CW; Weber MJ J Biol Chem; 1995 May; 270(20):12085-93. PubMed ID: 7538132 [TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy. Dowlati A; Nethery D; Kern JA Mol Cancer Ther; 2004 Apr; 3(4):459-63. PubMed ID: 15078989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]